| Dr Eli Tobias, MD, PHD | |
|
111 E Chestnut St, 43j, Chicago, IL 60611-2051 | |
| (312) 266-8454 | |
| Not Available |
| Full Name | Dr Eli Tobias |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 111 E Chestnut St, Chicago, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811106958 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eli Tobias, MD, PHD 111 E Chestnut St, 43j, Chicago, IL 60611-2051 Ph: (312) 266-8454 | Dr Eli Tobias, MD, PHD 111 E Chestnut St, 43j, Chicago, IL 60611-2051 Ph: (312) 266-8454 |
News Archive
SkylineDx, an innovative biotechnology company specialising in the development and commercialization of genetic tests, is today launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods.
In view of low attendance rate for colonoscopy screening for colorectal cancer (CRC), it is necessary to establish effective intervention methods to increase colonoscopy compliance. Many studies have reported that subjective or objective barriers prevent high-risk subjects from undergoing colonoscopy examination, which indicates that barrier-focused intervention might be effective. However, such barrier-focused intervention has not been reported in China.
Catasys, Inc. and Health Alliance Medical Plans today announced a multi-year agreement to offer Catasys' OnTrak Program to Health Alliance members in need in Illinois. OnTrak provides support and guidance to commercial, Medicaid and Medicare Advantage members struggling with both medical and behavioral conditions.
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced results from the Phase 1/2 clinical trial of OMS201, the Company's urological PharmacoSurgery™ product candidate.
Using gamma radiation to inactivate bacteria for the preparation of vaccines, instead of traditional heat or chemical methods of inactivation, appears to create a vaccine that is more effective than so-called "killed" vaccines against disease, and has the added advantage of a longer storage life than "live" vaccines.
› Verified 3 days ago
Peleg Horowitz, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 | |
Stephen Ondra, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-695-9797 | |
Adam Mendel Sonabend Worthalter, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 675 N Saint Clair St Ste 21-100, Chicago, IL 60611 Phone: 312-695-0990 | |
Kazuki Sakakura, Neurological Surgery Medicare: Medicare Enrolled Practice Location: 600 S Paulina St, Chicago, IL 60612 Phone: 628-628-6309 | |
Gail L Rosseau, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 4501 N Winchester Ave, 2nd Fl, Chicago, IL 60640 Phone: 773-250-0500 Fax: 773-250-0497 | |
Dr. Ravi Nunna, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1650 W Harrison St Ste 466, Chicago, IL 60612 Phone: 312-942-5495 | |
Tord Alden, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 2300 N Childrens Plz, Chicago, IL 60614 Phone: 773-880-4000 Fax: 773-281-1576 |